Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region, Achilles tendon insertion, Haglund’s deformity and plantar fascia insertion spurs.
To date, TX technology has successfully been used in over 90,000 cases.
Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region,...
Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region, Achilles tendon insertion, Haglund’s deformity and plantar fascia insertion spurs.
To date, TX technology has successfully been used in over 90,000 cases.
Copy to clipboard 
